Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
US Army
Argus Health
Healthtrust
Cipla
Fish and Richardson
Teva
McKesson
Cantor Fitzgerald

Generated: April 23, 2018

DrugPatentWatch Database Preview

AKRINOL Drug Profile

« Back to Dashboard

Which patents cover Akrinol, and when can generic versions of Akrinol launch?

Akrinol is a drug marketed by Schering and is included in one NDA.

The generic ingredient in AKRINOL is acrisorcin. Additional details are available on the acrisorcin profile page.
Summary for AKRINOL
US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 8
Patent Applications: 450
Drug Prices:see details
DailyMed Link:AKRINOL at DailyMed
Drug patent expirations by year for AKRINOL
Synonyms for AKRINOL
1,3-Benzenediol, 4-hexyl-, compd. with 9-acridinamine (1:1)
2U918O4BEV
4-HEXYLBENZENE-1,3-DIOL; ACRIDIN-9-AMINE
4-Hexylresorcinol compound with 9-aminoacridine (1:1)
7527-91-5
9-aminoacridine compd with 4-hexylresorcinol
9-Aminoacridine compd. with 4-hexylresorcinol (1:1)
9-AMINOACRIDINE; OXANA
AB00053836_02
AC1L2N8L
AC1Q79ZK
acridin-9-amine,4-hexylbenzene-1,3-diol
acridin-9-amine; 4-hexylbenzene-1,3-diol
ACRISORCIN
Acrisorcin (USAN/INN)
Acrisorcin [USAN:INN]
Acrisorcina
Acrisorcina [INN-Spanish]
Acrisorcinum
Acrisorcinum [INN-Latin]
Akrinol (TN)
Bis(9-aminoacridinium 4-hexyl-1,3-resorcindiolat
Bis(9-aminoacridinium)salz des hexylresorcine
BRD-M49658242-001-02-5
BRD-M49658242-001-03-3
BSPBio_002626
C13H10N2.C12H18O2
CCG-40100
CHEMBL1201038
D02759
D04VKS
DivK1c_006982
DTXSID10226234
EINECS 231-389-7
HMS1922H03
HMS2093C18
KBio1_001926
KBio2_000547
KBio2_003115
KBio2_005683
KBio3_002126
KBioGR_001210
KBioSS_000547
LP109140
LS-177177
NCGC00095115-01
NCGC00095115-02
NCGC00095115-03
NSC-758691
NSC758691
Pharmakon1600-01504218
PL007769
SBI-0052753.P002
Sch 7056
SCH-7056
SCHEMBL148836
SPBio_001214
SpecPlus_000886
Spectrum_000107
SPECTRUM1504218
Spectrum2_001107
Spectrum3_001213
Spectrum4_000625
Spectrum5_001392
UNII-2U918O4BEV

US Patents and Regulatory Information for AKRINOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering AKRINOL acrisorcin CREAM;TOPICAL 012470-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Chinese Patent Office
McKesson
Accenture
Boehringer Ingelheim
Teva
Chubb
Johnson and Johnson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.